- Presentations
- 2
- Markets
- 1
Inpefa is a brand of Sotagliflozin marketed by Lexicon Pharmaceuticals, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Sotagliflozin
- Brand owner
- Lexicon Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 200 mg tablet, 400 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Inpefa 200 mg tabletOral | Lexicon Pharmaceuticals | US FDA | Available on request |
| Inpefa 400 mg tabletOral | Lexicon Pharmaceuticals | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Inpefa
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.